Nikko Asset Management Americas, Inc. Beam Therapeutics Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $9.43 Billion
- Q2 2025
A detailed history of Nikko Asset Management Americas, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 4,726,799 shares of BEAM stock, worth $101 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
4,726,799
Previous 4,270,020
10.7%
Holding current value
$101 Million
Previous $83.4 Million
3.59%
% of portfolio
0.85%
Previous 1.12%
Shares
19 transactions
Others Institutions Holding BEAM
# of Institutions
247Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$213 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$207 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$188 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$162 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$101 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.5B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...